Abstract
Summary
Erythromycin Ethylsuccinate is the ethylsuccinate salt form of erythromycin, a broad-spectrum, topical macrolide antibiotic with antibacterial activity. Erythromycin ethylsuccinate diffuses through the bacterial cell membrane and reversibly binds to the 50S subunit of the bacterial ribosome. This prevents bacterial protein synthesis. Erythromycin ethylsuccinate may be bacteriostatic or bactericidal in action, depending on the concentration of the drug at the site of infection and the susceptibility of the organism involved.
Treatment of acute and chronic vaginal infections eg, vaginitis and vulvo-vaginitis, mixed infections and unspecific infections due to Gardnerella vaginalis, fungal infections caused by Candida albicans, trichomonal infections, and for pre- and postoperative disinfection of the vagina.
LPI (LP Information)' newest research report, the “Erythromycin Ethylsuccinate Industry Forecast” looks at past sales and reviews total world Erythromycin Ethylsuccinate sales in 2022, providing a comprehensive analysis by region and market sector of projected Erythromycin Ethylsuccinate sales for 2023 through 2029. With Erythromycin Ethylsuccinate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Erythromycin Ethylsuccinate industry.
This Insight Report provides a comprehensive analysis of the global Erythromycin Ethylsuccinate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Erythromycin Ethylsuccinate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Erythromycin Ethylsuccinate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Erythromycin Ethylsuccinate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Erythromycin Ethylsuccinate.
The global Erythromycin Ethylsuccinate market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Erythromycin Ethylsuccinate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Erythromycin Ethylsuccinate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Erythromycin Ethylsuccinate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Erythromycin Ethylsuccinate players cover Chemenu Inc., Acorn PharmaTech,LLC, BLD Pharm, Boc Sciences and Bide Pharmatech Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Erythromycin Ethylsuccinate market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
0.1g
0.25g
Segmentation by application
Anti-Bacterial Agents
Enzyme Inhibitors
Protein Synthesis Inhibitors
Gastrointestinal Agents
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Chemenu Inc.
Acorn PharmaTech,LLC
BLD Pharm
Boc Sciences
Bide Pharmatech Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Erythromycin Ethylsuccinate market?
What factors are driving Erythromycin Ethylsuccinate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Erythromycin Ethylsuccinate market opportunities vary by end market size?
How does Erythromycin Ethylsuccinate break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Treatment of acute and chronic vaginal infections eg, vaginitis and vulvo-vaginitis, mixed infections and unspecific infections due to Gardnerella vaginalis, fungal infections caused by Candida albicans, trichomonal infections, and for pre- and postoperative disinfection of the vagina.
LPI (LP Information)' newest research report, the “Erythromycin Ethylsuccinate Industry Forecast” looks at past sales and reviews total world Erythromycin Ethylsuccinate sales in 2022, providing a comprehensive analysis by region and market sector of projected Erythromycin Ethylsuccinate sales for 2023 through 2029. With Erythromycin Ethylsuccinate sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Erythromycin Ethylsuccinate industry.
This Insight Report provides a comprehensive analysis of the global Erythromycin Ethylsuccinate landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Erythromycin Ethylsuccinate portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Erythromycin Ethylsuccinate market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Erythromycin Ethylsuccinate and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Erythromycin Ethylsuccinate.
The global Erythromycin Ethylsuccinate market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Erythromycin Ethylsuccinate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Erythromycin Ethylsuccinate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Erythromycin Ethylsuccinate is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Erythromycin Ethylsuccinate players cover Chemenu Inc., Acorn PharmaTech,LLC, BLD Pharm, Boc Sciences and Bide Pharmatech Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Erythromycin Ethylsuccinate market by product type, application, key manufacturers and key regions and countries.
Market Segmentation:
Segmentation by type
0.1g
0.25g
Segmentation by application
Anti-Bacterial Agents
Enzyme Inhibitors
Protein Synthesis Inhibitors
Gastrointestinal Agents
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Chemenu Inc.
Acorn PharmaTech,LLC
BLD Pharm
Boc Sciences
Bide Pharmatech Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global Erythromycin Ethylsuccinate market?
What factors are driving Erythromycin Ethylsuccinate market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Erythromycin Ethylsuccinate market opportunities vary by end market size?
How does Erythromycin Ethylsuccinate break out type, application?
What are the influences of COVID-19 and Russia-Ukraine war?
Table of Contents
1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Erythromycin Ethylsuccinate Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Erythromycin Ethylsuccinate by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Erythromycin Ethylsuccinate by Country/Region, 2018, 2022 & 2029
2.2 Erythromycin Ethylsuccinate Segment by Type
2.2.1 0.1g
2.2.2 0.25g
2.3 Erythromycin Ethylsuccinate Sales by Type
2.3.1 Global Erythromycin Ethylsuccinate Sales Market Share by Type (2018-2023)
2.3.2 Global Erythromycin Ethylsuccinate Revenue and Market Share by Type (2018-2023)
2.3.3 Global Erythromycin Ethylsuccinate Sale Price by Type (2018-2023)
2.4 Erythromycin Ethylsuccinate Segment by Application
2.4.1 Anti-Bacterial Agents
2.4.2 Enzyme Inhibitors
2.4.3 Protein Synthesis Inhibitors
2.4.4 Gastrointestinal Agents
2.5 Erythromycin Ethylsuccinate Sales by Application
2.5.1 Global Erythromycin Ethylsuccinate Sale Market Share by Application (2018-2023)
2.5.2 Global Erythromycin Ethylsuccinate Revenue and Market Share by Application (2018-2023)
2.5.3 Global Erythromycin Ethylsuccinate Sale Price by Application (2018-2023)
3 Global Erythromycin Ethylsuccinate by Company
3.1 Global Erythromycin Ethylsuccinate Breakdown Data by Company
3.1.1 Global Erythromycin Ethylsuccinate Annual Sales by Company (2018-2023)
3.1.2 Global Erythromycin Ethylsuccinate Sales Market Share by Company (2018-2023)
3.2 Global Erythromycin Ethylsuccinate Annual Revenue by Company (2018-2023)
3.2.1 Global Erythromycin Ethylsuccinate Revenue by Company (2018-2023)
3.2.2 Global Erythromycin Ethylsuccinate Revenue Market Share by Company (2018-2023)
3.3 Global Erythromycin Ethylsuccinate Sale Price by Company
3.4 Key Manufacturers Erythromycin Ethylsuccinate Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Erythromycin Ethylsuccinate Product Location Distribution
3.4.2 Players Erythromycin Ethylsuccinate Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Erythromycin Ethylsuccinate by Geographic Region
4.1 World Historic Erythromycin Ethylsuccinate Market Size by Geographic Region (2018-2023)
4.1.1 Global Erythromycin Ethylsuccinate Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Erythromycin Ethylsuccinate Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Erythromycin Ethylsuccinate Market Size by Country/Region (2018-2023)
4.2.1 Global Erythromycin Ethylsuccinate Annual Sales by Country/Region (2018-2023)
4.2.2 Global Erythromycin Ethylsuccinate Annual Revenue by Country/Region (2018-2023)
4.3 Americas Erythromycin Ethylsuccinate Sales Growth
4.4 APAC Erythromycin Ethylsuccinate Sales Growth
4.5 Europe Erythromycin Ethylsuccinate Sales Growth
4.6 Middle East & Africa Erythromycin Ethylsuccinate Sales Growth
5 Americas
5.1 Americas Erythromycin Ethylsuccinate Sales by Country
5.1.1 Americas Erythromycin Ethylsuccinate Sales by Country (2018-2023)
5.1.2 Americas Erythromycin Ethylsuccinate Revenue by Country (2018-2023)
5.2 Americas Erythromycin Ethylsuccinate Sales by Type
5.3 Americas Erythromycin Ethylsuccinate Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Erythromycin Ethylsuccinate Sales by Region
6.1.1 APAC Erythromycin Ethylsuccinate Sales by Region (2018-2023)
6.1.2 APAC Erythromycin Ethylsuccinate Revenue by Region (2018-2023)
6.2 APAC Erythromycin Ethylsuccinate Sales by Type
6.3 APAC Erythromycin Ethylsuccinate Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Erythromycin Ethylsuccinate by Country
7.1.1 Europe Erythromycin Ethylsuccinate Sales by Country (2018-2023)
7.1.2 Europe Erythromycin Ethylsuccinate Revenue by Country (2018-2023)
7.2 Europe Erythromycin Ethylsuccinate Sales by Type
7.3 Europe Erythromycin Ethylsuccinate Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Erythromycin Ethylsuccinate by Country
8.1.1 Middle East & Africa Erythromycin Ethylsuccinate Sales by Country (2018-2023)
8.1.2 Middle East & Africa Erythromycin Ethylsuccinate Revenue by Country (2018-2023)
8.2 Middle East & Africa Erythromycin Ethylsuccinate Sales by Type
8.3 Middle East & Africa Erythromycin Ethylsuccinate Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Erythromycin Ethylsuccinate
10.3 Manufacturing Process Analysis of Erythromycin Ethylsuccinate
10.4 Industry Chain Structure of Erythromycin Ethylsuccinate
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Erythromycin Ethylsuccinate Distributors
11.3 Erythromycin Ethylsuccinate Customer
12 World Forecast Review for Erythromycin Ethylsuccinate by Geographic Region
12.1 Global Erythromycin Ethylsuccinate Market Size Forecast by Region
12.1.1 Global Erythromycin Ethylsuccinate Forecast by Region (2024-2029)
12.1.2 Global Erythromycin Ethylsuccinate Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Erythromycin Ethylsuccinate Forecast by Type
12.7 Global Erythromycin Ethylsuccinate Forecast by Application
13 Key Players Analysis
13.1 Chemenu Inc.
13.1.1 Chemenu Inc. Company Information
13.1.2 Chemenu Inc. Erythromycin Ethylsuccinate Product Portfolios and Specifications
13.1.3 Chemenu Inc. Erythromycin Ethylsuccinate Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Chemenu Inc. Main Business Overview
13.1.5 Chemenu Inc. Latest Developments
13.2 Acorn PharmaTech,LLC
13.2.1 Acorn PharmaTech,LLC Company Information
13.2.2 Acorn PharmaTech,LLC Erythromycin Ethylsuccinate Product Portfolios and Specifications
13.2.3 Acorn PharmaTech,LLC Erythromycin Ethylsuccinate Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 Acorn PharmaTech,LLC Main Business Overview
13.2.5 Acorn PharmaTech,LLC Latest Developments
13.3 BLD Pharm
13.3.1 BLD Pharm Company Information
13.3.2 BLD Pharm Erythromycin Ethylsuccinate Product Portfolios and Specifications
13.3.3 BLD Pharm Erythromycin Ethylsuccinate Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 BLD Pharm Main Business Overview
13.3.5 BLD Pharm Latest Developments
13.4 Boc Sciences
13.4.1 Boc Sciences Company Information
13.4.2 Boc Sciences Erythromycin Ethylsuccinate Product Portfolios and Specifications
13.4.3 Boc Sciences Erythromycin Ethylsuccinate Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Boc Sciences Main Business Overview
13.4.5 Boc Sciences Latest Developments
13.5 Bide Pharmatech Ltd.
13.5.1 Bide Pharmatech Ltd. Company Information
13.5.2 Bide Pharmatech Ltd. Erythromycin Ethylsuccinate Product Portfolios and Specifications
13.5.3 Bide Pharmatech Ltd. Erythromycin Ethylsuccinate Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Bide Pharmatech Ltd. Main Business Overview
13.5.5 Bide Pharmatech Ltd. Latest Developments
14 Research Findings and Conclusion